These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


610 related items for PubMed ID: 11340252

  • 21. Characterization of hemopoietic cell populations from human cord blood expressing c-kit.
    Reisbach G, Bartke I, Kempkes B, Kostka G, Ellwart J, Birner A, Thalmeier K, Mailhammer R, Bornkamm GW, Ullrich A.
    Exp Hematol; 1993 Jan; 21(1):74-9. PubMed ID: 7678090
    [Abstract] [Full Text] [Related]

  • 22. A comparative study of the phenotype and proliferative capacity of peripheral blood (PB) CD34+ cells mobilized by four different protocols and those of steady-phase PB and bone marrow CD34+ cells.
    To LB, Haylock DN, Dowse T, Simmons PJ, Trimboli S, Ashman LK, Juttner CA.
    Blood; 1994 Nov 01; 84(9):2930-9. PubMed ID: 7524760
    [Abstract] [Full Text] [Related]

  • 23. FLT3 ligand preserves the uncommitted CD34+CD38- progenitor cells during cytokine prestimulation for retroviral transduction.
    Nielsen SD, Husemoen LL, Sørensen TU, Gram GJ, Hansen JE.
    J Hematother Stem Cell Res; 2000 Oct 01; 9(5):695-701. PubMed ID: 11091493
    [Abstract] [Full Text] [Related]

  • 24. Cytokine-dependent ex vivo expansion of early subsets of CD34+ cord blood myeloid progenitors is enhanced by cord blood plasma, but expansion of the more mature subsets of progenitors is favored.
    Ruggieri L, Heimfeld S, Broxmeyer HE.
    Blood Cells; 1994 Oct 01; 20(2-3):436-54. PubMed ID: 7538350
    [Abstract] [Full Text] [Related]

  • 25. Comparison of the phenotype and clonogenicity of normal CD34+ cells from umbilical cord blood, granulocyte colony-stimulating factor-mobilized peripheral blood, and adult human bone marrow.
    Steen R, Tjønnfjord GE, Egeland T.
    J Hematother; 1994 Oct 01; 3(4):253-62. PubMed ID: 7537606
    [Abstract] [Full Text] [Related]

  • 26. Red cell depletion of umbilical cord blood (UCB): comparison between unmanipulated and red cell-depleted UCB by Ficoll-Paque density gradient separation.
    Kletzel M, Haut P, Atlas M, Olszewski M, Danner-Koptik K, Hubbell M.
    J Hematother; 1997 Jun 01; 6(3):269-72. PubMed ID: 9234182
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. In vitro growth and quantification of early (CD33-/CD38-) myeloid progenitor cells: stem cell factor requirement and effects of previous chemotherapy.
    Ferrero D, Cherasco C, Ortolano B, Giaretta F, Bruno B.
    Haematologica; 1999 May 01; 84(5):390-6. PubMed ID: 10329916
    [Abstract] [Full Text] [Related]

  • 30. Quantitative immunophenotypic characterization, cryopreservation, and enrichment of second- and third-trimester human fetal cord blood hematopoietic stem cells (progenitor cells).
    Surbek DV, Holzgreve W, Jansen W, Heim D, Garritsen H, Nissen C, Wodnar-Filipowicz A.
    Am J Obstet Gynecol; 1998 Nov 01; 179(5):1228-33. PubMed ID: 9822506
    [Abstract] [Full Text] [Related]

  • 31. Expansion of neutrophil precursors and progenitors in suspension cultures of CD34+ cells enriched from human bone marrow.
    Smith SL, Bender JG, Maples PB, Unverzagt K, Schilling M, Lum L, Williams S, Van Epps DE.
    Exp Hematol; 1993 Jul 01; 21(7):870-7. PubMed ID: 7686502
    [Abstract] [Full Text] [Related]

  • 32. High-efficiency retroviral transduction of fetal liver CD38-CD34++ cells: implications for in utero and ex utero gene therapy.
    Ohkubo T, Bárcena A, Smith CA, Harrison MR, Muench MO.
    Fetal Diagn Ther; 2001 Jul 01; 16(5):299-307. PubMed ID: 11509853
    [Abstract] [Full Text] [Related]

  • 33. CD133+ cell selection is an alternative to CD34+ cell selection for ex vivo expansion of hematopoietic stem cells.
    Kobari L, Giarratana MC, Pflumio F, Izac B, Coulombel L, Douay L.
    J Hematother Stem Cell Res; 2001 Apr 01; 10(2):273-81. PubMed ID: 11359674
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Ex vivo expansion of umbilical cord blood hematopoietic progenitor cells by combinations of cytokines.
    Urashima M, Hoshi Y, Akiyama M, Kamijo M, Kato Y, Akatsuka J, Maekawa K, Matsuzaki M, Ohnishi J, Kaihara C.
    Acta Paediatr Jpn; 1995 Apr 01; 37(2):160-5. PubMed ID: 7540792
    [Abstract] [Full Text] [Related]

  • 37. Biologic and phenotypic analysis of early hematopoietic progenitor cells in umbilical cord blood.
    Almici C, Carlo-Stella C, Wagner JE, Mangoni L, Garau D, Rizzoli V.
    Leukemia; 1997 Dec 01; 11(12):2143-9. PubMed ID: 9447833
    [Abstract] [Full Text] [Related]

  • 38. Ex vivo expansion of T, NK and CD34+ cells from umbilical cord blood.
    Wei YM, Cao Q, Zhou HY, Xia R, Lan JC, Meng FY, Bai H.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec 01; 13(6):1076-81. PubMed ID: 16403284
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 31.